Amgen extends autoimmune pact with small Michigan biotech
Amgen is going all in on a three-indication collaboration with an Ann Arbor, MI biotech.
The California pharma has elected to move forward with all …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.